Merck gets ahead of the Curve, inking oncology and neurology drug discovery deal with emerging British biotech

Merck has wandered off the beaten path to find a partner that can help it discover small molecule drug candidates against tough oncology and neurology targets. The deal sees Curve Therapeutics, working out of a site on the U.K.’s south coast, team up with Merck in a deal worth up to $1.7 bil